A Phase Ib Multi-Cohort Study of MK-3475 in Subjects with Advanced Solid Tumors

Conditions

Bladder | Breast - Female | Lip, Oral Cavity and Pharynx | Stomach

What is the purpose of this trial?

This study is being done to investigate the safety, tolerability and anti-tumor activity of MK-3475 in participants with advanced triple negative breast cancer (TNBC), advanced head and neck cancer, advanced urothelial cancer, or advanced gastric cancer.


Participation Guidelines

Age:
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Merck Sharp & Dohme
Dates:
08/28/2013
Last Updated:
Study HIC#:
1306012177